Psychiatry & Neurology Doctors in Salem, VA Accepting Medicare

46 Psychiatry & Neurology doctors found. Showing 41 - 46

Linda Ann Lee, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 1970 Roanoke Blvd, Salem, VA 24153 Phone: 540-982-2463    Fax: 434-316-7071

Manjula Sathish, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 1902 Braeburn Dr Ste 130, Salem, VA 24153 Phone: 540-444-0460    Fax: 540-444-0479

Dr. Leonard Jeffrey Marcus, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 1970 Roanoke Blvd, Salem, VA 24153 Phone: 540-982-2463    Fax: 540-855-3452

Timothy L Hormel, MD Psychiatry & Neurology - Neurology Medicare: Accepting Medicare Assignments Practice Location: 1942 Braeburn Cir, Salem, VA 24153 Phone: 540-725-3500    Fax: 540-725-4449

Dr. Alan Michael Cooper, M.D. Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 1970 Roanoke Blvd, Salem, VA 24153 Phone: 540-982-2463

Joseph Froelich Smith, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 1802 Braeburn Dr, Salem, VA 24153 Phone: 540-772-3485    Fax: 540-772-3486

News Archive

ZIOPHARM Oncology announces guidance on palifosfamide Phase III trial in metastatic soft tissue sarcoma

ZIOPHARM Oncology, Inc. announced guidance today regarding the Company's planned pivotal Phase III trial for palifosfamide in metastatic soft tissue sarcoma, including details of the proposed study's design, timing and regulatory review.

PET with 11C-PIB can positively visualize amyloid deposits in the heart

While amyloid imaging may now be most associated with detecting plaques in the brain, it has the potential to change the way cardiac amyloidosis is diagnosed. According to first-of-its-kind research published in the February issue of The Journal of Nuclear Medicine, positron emission tomography (PET) with 11C-PIB can positively visualize amyloid deposits in the heart.

Abbott commences elagolix Phase 3 trial in endometriosis

Abbott, in cooperation with Neurocrine Biosciences, Inc., today announced the initiation of a pivotal Phase 3 clinical trial designed to evaluate the safety and efficacy of elagolix in female patients with endometriosis.

Firefly surgical technology sheds new light on kidney cancers

A surgical technology called Firefly is shedding new light on kidney cancers and helping doctors at MedStar Georgetown University Hospital remove tumors more safely and more efficiently while sparing the rest of the healthy kidney.

Signaling pathway might determine genetic susceptibility for fetal alcohol spectrum disorder

Fetal alcohol syndrome is the leading preventable cause of developmental disorders in developed countries. And fetal alcohol spectrum disorder (FASD), a range of alcohol-related birth defects that includes fetal alcohol syndrome, is thought to affect as many as 1 in 100 children born in the United States.

Read more Medical News

› Verified 5 days ago

• 1
• 2
• 3(current)